Publication
Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma.
Grace Elsey, James A Davis, Kelley Julian, Rebecca Gonzalez, Jordan Snyder, Mikhaila Rice, Victoria R Nachar, Jessica McElwee, Shebli Atrash, Christopher Cahoon, Baylee Bryan, Douglas W Sborov, Katelynn Granger, Matthew Warrick, Anthony Dominick, Doris K Hansen, Ariel Grajales-Cruz, Zahra Mahmoudjafari, Joslyn Rudoni, Jonathan Kissam, Megan Vince, Jack Khouri, Iman Ahmed, Matthew Pianko, Donald C Moore
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
OBJECTIVE: To compare the incidence and severity of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) between two different step-up dosing (SUD) schedules with talquetamab, the standard SUD schedule of Days 1, 4, 7, and 10 and a condensed SUD…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMultiple Myelomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available